MarketBeat Instant News Alerts 2 hours agoNatWest Group (LON:NWG) Posts Quarterly Earnings ResultsMarketBeatNatWest Group (LON:NWG - Get Free Report) released its quarterly earnings results on Friday. The company reported GBX 19.80 earnings per share for the quarter. NatWest Group had a return on equity of 13.29% and a net margin of 18.21%.LON:NWGRead NatWest Group (LON:NWG) Posts Quarterly Earnings Results2 hours agoFFD Financial (OTCMKTS:FFDF) Posts Quarterly Earnings ResultsMarketBeatFFD Financial (OTCMKTS:FFDF - Get Free Report) announced its earnings results on Friday. The bank reported $1.26 earnings per share for the quarter. FFD Financial had a net margin of 26.38% and a return on equity of 17.51%. OTCMKTS:FFDFRead FFD Financial (OTCMKTS:FFDF) Posts Quarterly Earnings Results2 hours agoWeiss Ratings Reaffirms "Sell (D)" Rating for Adient (NYSE:ADNT)MarketBeatWeiss Ratings reiterated a "sell (d)" rating on shares of Adient in a report on Friday.NYSE:ADNTRead Weiss Ratings Reaffirms "Sell (D)" Rating for Adient (NYSE:ADNT)2 hours agoAdecoagro (NYSE:AGRO) Earns Sell (D+) Rating from Weiss RatingsMarketBeatWeiss Ratings reiterated a "sell (d+)" rating on shares of Adecoagro in a report on Friday.NYSE:AGRORead Adecoagro (NYSE:AGRO) Earns Sell (D+) Rating from Weiss Ratings2 hours agoAddus HomeCare (NASDAQ:ADUS) Receives Hold (C+) Rating from Weiss RatingsMarketBeatWeiss Ratings reiterated a "hold (c+)" rating on shares of Addus HomeCare in a report on Friday.NASDAQ:ADUSRead Addus HomeCare (NASDAQ:ADUS) Receives Hold (C+) Rating from Weiss Ratings2 hours agoADC Therapeutics' (ADCT) "Sell (D-)" Rating Reaffirmed at Weiss RatingsMarketBeatWeiss Ratings reaffirmed a "sell (d-)" rating on shares of ADC Therapeutics in a research report on Friday.NYSE:ADCTRead ADC Therapeutics' (ADCT) "Sell (D-)" Rating Reaffirmed at Weiss Ratings Trending News1D-Wave Quantum (NYSE:QBTS) Stock Price Down 6.2% - Here's Why2Oracle (NYSE:ORCL) Stock Price Down 4.9% - Here's What Happened3Nebius Group (NBIS) to Release Earnings on Wednesday4Plug Power (NASDAQ:PLUG) Shares Down 8.2% - Here's Why5Oracle (NYSE:ORCL) EVP Sells $1,403,100.00 in Stock6Nebius Group (NASDAQ:NBIS) Shares Down 3.9% - Time to Sell?7CoreWeave (NASDAQ:CRWV) Stock Price Down 7.2% After Insider Selling8Rolls-Royce Holdings plc (LON:RR) Shares Down 2.8% - Here's What Happened All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoAdaptive Biotechnologies' (ADPT) "Sell (D-)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:ADPTRead Adaptive Biotechnologies' (ADPT) "Sell (D-)" Rating Reiterated at Weiss Ratings2 hours agoAdaptHealth's (AHCO) Sell (D+) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:AHCORead AdaptHealth's (AHCO) Sell (D+) Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reiterates Buy (B) Rating for Acushnet (NYSE:GOLF)MarketBeatNYSE:GOLFRead Weiss Ratings Reiterates Buy (B) Rating for Acushnet (NYSE:GOLF)2 hours agoAcuity (NYSE:AYI) Earns "Buy (B-)" Rating from Weiss RatingsMarketBeatNYSE:AYIRead Acuity (NYSE:AYI) Earns "Buy (B-)" Rating from Weiss Ratings2 hours agoACRES Commercial Realty's (ACR) "Hold (C-)" Rating Reiterated at Weiss RatingsMarketBeatNYSE:ACRRead ACRES Commercial Realty's (ACR) "Hold (C-)" Rating Reiterated at Weiss Ratings2 hours agoAccuray (NASDAQ:ARAY) Receives Sell (E+) Rating from Weiss RatingsMarketBeatNASDAQ:ARAYRead Accuray (NASDAQ:ARAY) Receives Sell (E+) Rating from Weiss Ratings2 hours agoWeiss Ratings Reiterates Sell (D+) Rating for Acco Brands (NYSE:ACCO)MarketBeatNYSE:ACCORead Weiss Ratings Reiterates Sell (D+) Rating for Acco Brands (NYSE:ACCO)2 hours agoWeiss Ratings Reaffirms Hold (C) Rating for Accel Entertainment (NYSE:ACEL)MarketBeatNYSE:ACELRead Weiss Ratings Reaffirms Hold (C) Rating for Accel Entertainment (NYSE:ACEL)2 hours agoAcadian Asset Management (NYSE:AAMI) Downgraded by Weiss Ratings to "Hold (C+)"MarketBeatNYSE:AAMIRead Acadian Asset Management (NYSE:AAMI) Downgraded by Weiss Ratings to "Hold (C+)"2 hours agoAcadia Realty Trust (NYSE:AKR) Given "Hold (C)" Rating at Weiss RatingsMarketBeatNYSE:AKRRead Acadia Realty Trust (NYSE:AKR) Given "Hold (C)" Rating at Weiss Ratings2 hours agoWeiss Ratings Reiterates "Hold (C)" Rating for ABM Industries (NYSE:ABM)MarketBeatNYSE:ABMRead Weiss Ratings Reiterates "Hold (C)" Rating for ABM Industries (NYSE:ABM)2 hours agoAbbott Laboratories (NYSE:ABT) Earns Buy (B) Rating from Weiss RatingsMarketBeatNYSE:ABTRead Abbott Laboratories (NYSE:ABT) Earns Buy (B) Rating from Weiss Ratings2 hours agoAAR's (AIR) "Hold (C-)" Rating Reiterated at Weiss RatingsMarketBeatNYSE:AIRRead AAR's (AIR) "Hold (C-)" Rating Reiterated at Weiss Ratings2 hours agoA2Z Cust2Mate Solutions (NASDAQ:AZ) Given "Sell (D-)" Rating at Weiss RatingsMarketBeatNASDAQ:AZRead A2Z Cust2Mate Solutions (NASDAQ:AZ) Given "Sell (D-)" Rating at Weiss Ratings2 hours agoA10 Networks' (ATEN) Hold (C+) Rating Reaffirmed at Weiss RatingsMarketBeatNYSE:ATENRead A10 Networks' (ATEN) Hold (C+) Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Sell (D-) Rating for a.k.a. Brands (NYSE:AKA)MarketBeatNYSE:AKARead Weiss Ratings Reaffirms Sell (D-) Rating for a.k.a. Brands (NYSE:AKA)2 hours agoA. O. Smith (NYSE:AOS) Earns "Hold (C+)" Rating from Weiss RatingsMarketBeatNYSE:AOSRead A. O. Smith (NYSE:AOS) Earns "Hold (C+)" Rating from Weiss Ratings2 hours ago908 Devices (NASDAQ:MASS) Receives "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:MASSRead 908 Devices (NASDAQ:MASS) Receives "Sell (D-)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reiterates "Sell (D-)" Rating for 8X8 (NASDAQ:EGHT)MarketBeatNASDAQ:EGHTRead Weiss Ratings Reiterates "Sell (D-)" Rating for 8X8 (NASDAQ:EGHT)2 hours ago89BIO's (ETNB) "Sell (D-)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:ETNBRead 89BIO's (ETNB) "Sell (D-)" Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reaffirms "Sell (E+)" Rating for 5E Advanced Materials (NASDAQ:FEAM)MarketBeatNASDAQ:FEAMRead Weiss Ratings Reaffirms "Sell (E+)" Rating for 5E Advanced Materials (NASDAQ:FEAM)2 hours ago4D Molecular Therapeutics (NASDAQ:FDMT) Earns Sell (D-) Rating from Weiss RatingsMarketBeatNASDAQ:FDMTRead 4D Molecular Therapeutics (NASDAQ:FDMT) Earns Sell (D-) Rating from Weiss Ratings2 hours ago3M (NYSE:MMM) Earns "Buy (B-)" Rating from Weiss RatingsMarketBeatNYSE:MMMRead 3M (NYSE:MMM) Earns "Buy (B-)" Rating from Weiss Ratings2 hours ago3D Systems (NYSE:DDD) Receives "Sell (D-)" Rating from Weiss RatingsMarketBeatNYSE:DDDRead 3D Systems (NYSE:DDD) Receives "Sell (D-)" Rating from Weiss Ratings Featured Articles and OffersJPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?By Leo Miller | October 19, 2025Buy alert: Move $1,000 before Tesla’s Optimus launchFrom Altimetry (Ad)Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done YetBy Dan Schmidt | October 20, 2025Archer’s Recent String of Victories Signals a New Phase of GrowthBy Jeffrey Neal Johnson | October 22, 20252 Ways to Trade Qualcomm Ahead of November’s EarningsBy Sam Quirke | October 21, 2025AI's Next Magnificent SevenFrom The Oxford Club (Ad)The Best AI for Picking Stocks, Ranked by PerformanceBy Thomas Hughes | October 23, 2025Warner Bros. Bidding War Potential: How High Could WBD Shares Go?By Leo Miller | October 23, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
